Tracey E Toms

Summary

Publications

  1. pmc Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands, UK
    Arthritis Res Ther 10:R145. 2008
  2. pmc Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands, UK
    Arthritis Res Ther 11:R110. 2009
  3. doi request reprint Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation
    Dimitrios Daoussis
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Pensnett Road, Dudley, West Midlands, DY1 2HQ, UK
    Clin Rheumatol 30:477-84. 2011
  4. doi request reprint Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis?
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands, UK
    Angiology 62:167-75. 2011
  5. doi request reprint Prevalence of risk factors for statin-induced myopathy in rheumatoid arthritis patients
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands, UK
    Musculoskeletal Care 8:2-9. 2010
  6. doi request reprint Target organ damage in patients with rheumatoid arthritis: the role of blood pressure and heart rate
    Vasileios F Panoulas
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, West Midlands, UK
    Atherosclerosis 209:255-60. 2010
  7. ncbi request reprint Association of mean platelet volume with hypertension in rheumatoid arthritis
    Armen Yuri Gasparyan
    Clinical Research Unit, Russell s Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust Teaching, Dudley, West Midlands, UK
    Inflamm Allergy Drug Targets 9:45-50. 2010
  8. doi request reprint Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands DY1 2HQ, UK
    Ann Rheum Dis 70:1025-32. 2011
  9. doi request reprint Apolipoprotein E gene polymorphisms are strong predictors of inflammation and dyslipidemia in rheumatoid arthritis
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands, DY1 2HQ, UK
    J Rheumatol 39:218-25. 2012
  10. doi request reprint Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Pensnett Road, Dudley, West Midlands, UK
    Ann Rheum Dis 69:683-8. 2010

Detail Information

Publications18

  1. pmc Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands, UK
    Arthritis Res Ther 10:R145. 2008
    ..We examined whether GC exposure associates with the presence of metabolic syndrome in patients with RA...
  2. pmc Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands, UK
    Arthritis Res Ther 11:R110. 2009
    ..We aimed to: assess the prevalence of the MetS in RA; identify factors that associate with its presence; and assess their interaction with the potential influence of MTX...
  3. doi request reprint Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation
    Dimitrios Daoussis
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Pensnett Road, Dudley, West Midlands, DY1 2HQ, UK
    Clin Rheumatol 30:477-84. 2011
    ..Given the association of MA with MetS, future prospective studies are needed to establish the use of MA as a screening tool for RA patients at increased CVD risk...
  4. doi request reprint Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis?
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands, UK
    Angiology 62:167-75. 2011
    ..In summary, the effects of inflammation on individual lipid levels may underestimate lipid-associated cardiovascular disease (CVD) risk in RA, thus lipid ratios may be more appropriate for CVD risk stratification in RA...
  5. doi request reprint Prevalence of risk factors for statin-induced myopathy in rheumatoid arthritis patients
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands, UK
    Musculoskeletal Care 8:2-9. 2010
    ..We aimed to identify the frequency of risk factors for statin-induced myopathy and establish whether the rs4149056 genotype is more prevalent in RA...
  6. doi request reprint Target organ damage in patients with rheumatoid arthritis: the role of blood pressure and heart rate
    Vasileios F Panoulas
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, West Midlands, UK
    Atherosclerosis 209:255-60. 2010
    ..Inflammation and sympathetic overdrive may also associate with TOD. We investigated the prevalence and associations of TOD in RA...
  7. ncbi request reprint Association of mean platelet volume with hypertension in rheumatoid arthritis
    Armen Yuri Gasparyan
    Clinical Research Unit, Russell s Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust Teaching, Dudley, West Midlands, UK
    Inflamm Allergy Drug Targets 9:45-50. 2010
    ..3-3.7; P=0.003). It is possible that MPV as a surrogate marker of platelet function reflects enhanced vascular risk. To further explore the role of MPV as a marker for cardiovascular risk in RA, prospective studies are warranted...
  8. doi request reprint Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands DY1 2HQ, UK
    Ann Rheum Dis 70:1025-32. 2011
    ..The authors assessed whether RA susceptibility genes associate with the presence of dyslipidaemia in RA patients...
  9. doi request reprint Apolipoprotein E gene polymorphisms are strong predictors of inflammation and dyslipidemia in rheumatoid arthritis
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands, DY1 2HQ, UK
    J Rheumatol 39:218-25. 2012
    ..We compared the frequency of 2 ApoE single-nucleotide polymorphisms (SNP) in patients with RA and controls, and studied the relationship of ApoE genotypes with lipids and inflammation in RA...
  10. doi request reprint Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Pensnett Road, Dudley, West Midlands, UK
    Ann Rheum Dis 69:683-8. 2010
    ..We aimed to (a) identify the proportion of at risk patients with rheumatoid arthritis (RA) requiring statin therapy identified by conventional risk calculators, and (b) assess whether patients at risk were receiving statins...
  11. doi request reprint Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis
    Aamer Sandoo
    Department of Rheumatology, Dudley Group NHS Foundation Trust, Russells Hall Hospital, Dudley, West Midlands, UK
    Clin Biochem 45:1399-403. 2012
    ..The aim of the present longitudinal study was to investigate the effects of tumour necrosis factor alpha (TNFα) antagonists on serum concentrations of ADMA in RA patients...
  12. pmc Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis
    George S Metsios
    Department of physical activity, Exercise and Health, University of Wolverhampton, Gorway Road, Walsall, WS13BD, West Midlands, UK
    Arthritis Res Ther 13:R108. 2011
    ..We hypothesised that disease activity/severity and physical activity are major predictors for the need of hospitalisation in patients with RA...
  13. pmc Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a pilot study
    Aamer Sandoo
    Department of Rheumatology, Dudley Group of Hospitals NHS Foundation Trust, Russells Hall Hospital, Pensnett Road, Dudley, West Midlands, DY1 2HQ, United Kingdom
    BMC Musculoskelet Disord 13:127. 2012
    ..In this longitudinal study we hypothesised that anti-tumor necrosis factor-α (anti-TNFα) therapy in patients with active RA improves HDL cholesterol, microvascular and macrovascular endothelial function...
  14. ncbi request reprint The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases
    Armen Yuri Gasparyan
    Department of Rheumatology, Clinical Research Unit, Russells Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, Dudley DY1 2HQ, West Midlands, UK
    Curr Vasc Pharmacol 8:437-49. 2010
    ....
  15. doi request reprint Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis
    Vasileios F Panoulas
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands, UK
    Endothelium 15:203-12. 2008
    ..These findings, if replicated in future studies, could be used as a screening tool for RA patients at increased hypertension, and thus cardiovascular, risk...
  16. doi request reprint Rheumatoid arthritis: is it a coronary heart disease equivalent?
    Holly John
    Department of Rheumatology, Dudley Group of Hospitals NHS Foundation Trust, Dudley, UK
    Curr Opin Cardiol 26:327-33. 2011
    ..This review examines current evidence to address the question whether rheumatoid arthritis (RA) is a coronary heart disease equivalent, similar to type 2 diabetes mellitus (DM2)...
  17. pmc Dyslipidaemia in rheumatological autoimmune diseases
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands, UK
    Open Cardiovasc Med J 5:64-75. 2011
    ..In this review, we discuss the association between several of the rheumatological autoimmune diseases and dyslipidaemia, and the potential cardiovascular impact this may confer...
  18. ncbi request reprint Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors
    Tracey E Toms
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, West Midlands DY1 2HQ, UK
    Curr Vasc Pharmacol 8:301-26. 2010
    ..In this review, we discuss lipid abnormalities specifically in the context of RA and highlight the potential impact of inflammation, genetic factors, lifestyle, and anti-rheumatic drugs on lipid metabolism...